Co-Bisoprolol Sandoz 5 mg - 12.5 mg (bisoprolol + hydrochloorthiazide) · CNK 2697621

Product information

Product name
Co-Bisoprolol Sandoz 5 mg - 12.5 mg
Pack
100
Active ingredient
bisoprolol + hydrochloorthiazide
CNK Code
2697621
Availability score
0 / 10
Historic availability score
Locked

Product properties

CAS code
104344-23-2
ATC code
C07BB07
Company
Sandoz
Pharmaceutical form
Film-coated tablet
Ex-factory price
€4.58
Authorisation number
BE361672
GTIN
07613421010935
Delivery mode
M1
Delivery environment
Public
CTI Extended
361672-08

Pharmacist Assessment

Assessment title
Commercialization officially ended — no stock
Assessment description

SAM has flagged this product as commercially stopped (reason: Commercial reasons) and no stock is available from wholesalers. Switching to an alternative is necessary.

Recommended alternative

Assessment alternative
Co-Bisoprolol EG 5 mg - 12.5 mg (CNK 2574804) — Score: 9.78/10

Equivalent products

Tier A: Direct equivalents

…

Tier B: Galenic alternatives

…

Tier C: Strength alternatives

…

Tier D: ATC equivalents (parallel import)

…

Tier E: Active substances (magistral)

…

Stock overview

Availability in Freemium
  • 0 of 18 warehouse locations have stock
  • 0 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Available alternatives
Magistral alternative available 2

Status history (PharmaStatus)

Commercialization stopped Active
- present

Commercial reasons

Alternative available

Composition

4 ingredients

Ingredients
Substance Type Strength CAS
Substance
Hydrochloorthiazide
Type
Active ingredient
Strength
12.5 mg
CAS
58-93-5
Substance
Bisoprololfumaraat
Type
Active ingredient
Strength
5 mg
CAS
104344-23-2
Substance
Lactosemonohydraat
Type
Excipient
Strength
CAS
Substance
Lactosemonohydraat
Type
Excipient
Strength
CAS

Additional information

Leaflet
Download leaflet
SPC
Download SPC
BCPI
View on BCPI
PharmaStatus
View on PharmaStatus

Availability statistics

Current status
Commercialization stopped
Days unavailable (last year)
337 days
Number of status changes
2
Active supply problems
0
Last change
30/01/2026